Journal Guide

Blood Cancer Journal is a peer-reviewed, online, open access, sister journal to the well-established and highly respected, Leukemia (2011 impact factor 9.561, Journal Citation Reports, Thomson Reuters, 2011), bringing to the fore outstanding pre-clinical and clinical research in the field of hematology, with ramifications into translational biology research down to new therapies. Topics of particular concentration will include, but are not limited to, the following:

Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation.The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 12 issues a year.

The role of the BDJ is to inform its readers of ideas, opinions, developments and key issues in dentistry - clinical, practical and scientific - stimulating interest, debate and discussion amongst dentists of all disciplines. All papers published in the BDJ are subject to rigorous peer review.AudienceAll dentists, dental undergraduates, members of the dental team, hospital, community, academic and general practitionersContentThe BDJ has been designed to help readers find the relevant information fast and easily. Each journal is divided into sections so you can find what you want. * Opinion section: leaders, letters and articles expressing the views and opinions of people that are open to debate and discussion. This section will keep you aware of what people are thinking in dentistry today, and introduce differing views for debate. * News: here you will be able to read general news about the dental industry and update yourself on the latest research and diary events. * Practice section: articles, reports and papers on the latest developments and information relevant for those in dental practice. This section contains our clinical guide series, how-to-do-it papers, dental business articles and interviews, case reports and general articles about clinical matters, politics and trends. * Research section: scientific peer-reviewed papers with a focus on clinical research to enable researchers and scientists to communicate their findings to the rest of the community. * Summaries: this section acts as a bridge between the practice and research sections, providing a summary of the research papers in this issue. Besides the abstract and 'in brief' box this page includes a comment on each paper by a specialist in the field, emphasising the relevance of the paper. This section ensures that the information from the research is easily available to both practitioners and researchers. This section also includes a selection of abstracts from dental journals. * Education section: any type of paper, article or report that is relevant to the vital subject of dental education, whether it is undergraduate, postgraduate, specialist or lifelong learning * Trade News: the latest news of new products * Plus: This section caries a selection of other articles such as reviews of relevant books and CD Roms, obituaries, parliamentary updates and the entertaining View From The Chair.

Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences. British Journal of Cancer (BJC) exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients. BJC works with a distinguished team of international experts to ensure the highest standards of selection and review. All relevant papers are carefully considered. Once accepted, papers are published rapidly in print and online.Full research papers and short communications are published under five broad headings: * clinical studies * translational therapeutics * molecular diagnostics * genetics and genomics * epidemiologyBJC regularly invites minireviews on topics of current interest from international authorities. Some longer reviews, and book reviews are published, usually by editor's invitation. Editorials and letters to the editor on matters arising from published papers are also published at the editor's discretion.BJC is owned by Cancer Research UK, the world's leading independent charity dedicated to cancer research. Cancer Research UK carries out scientific research to find news ways of preventing, diagnosing and treating cancer; ensuring findings are used to benefit the lives of cancer patients.BJC reflects this purpose. It was founded more than sixty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. Broad coverage, its editorial independence and consistent high standards have made British Journal of Cancer one of the world's premier general cancer journals.

Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; preliminary communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.

Cell Death & Differentiation is a journal devoted to the cell biology, molecular biology and biochemistry of cell death and differentiation, both in normal tissue regulation and in disease. To this end, Cell Death & Differentiation provides a unified forum for scientists as well as clinicians. It is committed to the rapid publication of high quality original papers that relate to these subjects, together with topical, usually solicited, reviews, meeting reports, editorial correspondence and occasional commentaries on controversial and scientifically informative issues.

Cell Death & Disease is a peer-reviewed open access online journal that will publish full-length papers, reviews and commentaries describing original research in the field of translational cell death. It seeks to promote diverse and integrated areas of Experimental and Internal Medicine with its specialities, including Cancer, Immunity and Neuroscience.Cell Death & Disease seeks to encompass the breadth of translational implications of cell death, and topics of particular concentration will include, but are not limited to, the following:* Experimental medicine* Cancer* Immunity* Internal medicine* Neuroscience.

cell growth and differentiation, signal transduction, apoptosis, stem cells, development, immunology

Cell Research publishes results of significance and originality in all disciplines of cell biology and molecular biology. The journal has an international authorship and a broad scope in basic research including: * Cell growth, differentiation & apoptosis * Signal transduction * Stem cell biology & development * Chromatin, epigenetics & transcription * miRNA function & mechanism * Cancer biology * Immunity & molecular pathogenesis * Molecular & cellular neuroscience * Plant cell biology * Genomics & proteomicsCell Research is published by Nature Publishing Group in partnership with the Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS). In CR the Editorial team and NPG provide readers with high quality original articles and sharply focused reviews and commentaries which span the life sciences. CR is China's best journal in the Life Sciences and it is a valued member of NPG's highly respected family of Molecular Cell Biology journals.Cell Research, which publishes exclusively in English, is China's leading journal in the life sciences.

Cellular & Molecular Immunology is a bimonthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications, Cellular & Molecular Immunology provides the latest information and advancements in our understanding of the immunological response of the host, both in vitro and in vivo.The journal publishes Research Articles, Reviews, Minireviews and Brief Reports in all areas of cellular and molecular immunology, including but not limited to: * clinical immunology * comparative immunology * immunobiology * immunogenetics * immunological techniques * immunopathology * immunopharmacology * infection immunology * neuroimmunology * transplantation immunology * tumor immunology * veterinary immunologyAs China's first English-language immunology journal, Cellular & Molecular Immunology is designed to serve both the Chinese and international communities as a vehicle to rapidly disseminate the latest studies in this field. The journal welcomes submissions that explore novel ideas or un- or contra-orthodox approaches, as long as they are underpinned by conventional scientific practice and present falsifiable hypotheses that are tested with empirical methods and evidence.Manuscripts must provide evidence that can be critically evaluated, and where applicable: * define disorders and clinical symptoms by standard clinical terms (e.g. allergy, asthma, lupus, etc.) * deem results 'significant' only using standard statistical methods in biological effects/outcomes studies * use consistent and defined amounts and mixtures of herbal formulas, or use purified monomer extracts.Terms that may be ambiguous to the broad audience of the journal should be clearly defined within the manuscript.